# Centaur Pharmaceuticals Private Limited – FDA Inspection, Jan 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/centaur-pharmaceuticals-private-limited/f92de877-2291-4ba5-8c40-c39fd827d609
Source feed: FDA_Inspections

> FDA inspection 1195193 of Centaur Pharmaceuticals Private Limited, January 13, 2023. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195193
- Company Name: Centaur Pharmaceuticals Private Limited
- Inspection Date: 2023-01-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 7

## Related Documents

- FDA Inspection 1297060 - 2025-11-14

## Related Officers

- [Investigator](https://www.keypedia.com/people/sandra-a-boyd/c469103a-0917-407a-b9d1-98273358dfeb)

Company: https://www.keypedia.com/companies/centaur-pharmaceuticals-private-limited/429667f3-78f8-45f1-b2ac-da0509f3e48d

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
